Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
198 USD | +0.87% | +2.94% | +15.12% |
Mar. 06 | ResMed Inc. Announces the U.S. Launch of the AirFit F40 | CI |
Mar. 06 | Morgan Stanley Adjusts Resmed’s Price Target to AU$31.80 From AU$28.60, Keeps at Overweight | MT |
Financials (USD)
Sales 2024 * | 4.64B | Sales 2025 * | 4.95B | Capitalization | 29.09B |
---|---|---|---|---|---|
Net income 2024 * | 977M | Net income 2025 * | 1.16B | EV / Sales 2024 * | 6.41 x |
Net Debt 2024 * | 636M | Net cash position 2025 * | 203M | EV / Sales 2025 * | 5.84 x |
P/E ratio 2024 * |
30.3
x | P/E ratio 2025 * |
26.1
x | Employees | 10,140 |
Yield 2024 * |
0.99% | Yield 2025 * |
1.06% | Free-Float | 77.08% |
Latest transcript on ResMed, Inc.
1 day | +0.87% | ||
1 week | +2.94% | ||
Current month | +13.99% | ||
1 month | +9.41% | ||
3 months | +14.48% | ||
6 months | +33.22% | ||
Current year | +15.12% |
Managers | Title | Age | Since |
---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 51 | 00-08-31 |
Peter Farrell
FOU | Founder | 81 | 89-05-31 |
Leo Toole
DFI | Director of Finance/CFO | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 51 | 00-08-31 |
Ron Taylor
BRD | Director/Board Member | 76 | 04-12-31 |
Peter Farrell
FOU | Founder | 81 | 89-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.09% | 18 M€ | +7.01% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 198 | +0.87% | 601,705 |
24-03-27 | 196.3 | +1.11% | 567,412 |
24-03-26 | 194.2 | +0.45% | 1,108,903 |
24-03-25 | 193.3 | +0.68% | 1,836,891 |
24-03-22 | 192 | -0.89% | 1,130,264 |
Delayed Quote Nyse, March 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.12% | 28.84B | |
+9.50% | 221B | |
+7.95% | 184B | |
+18.30% | 142B | |
+18.47% | 101B | |
+7.83% | 68.07B | |
+25.32% | 57.27B | |
-3.69% | 47.42B | |
+4.66% | 43.19B | |
-1.38% | 22.04B |